145 related articles for article (PubMed ID: 2200537)
1. The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors.
Sharkis SJ; Jones RJ; Bellis ML; Demetri GD; Griffin JD; Civin C; May WS
Blood; 1990 Aug; 76(4):716-20. PubMed ID: 2200537
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
3. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
Grant S; Pettit GR; Howe C; McCrady C
Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
[TBL] [Abstract][Full Text] [Related]
4. Action of interleukin-3, G-CSF, and GM-CSF on highly enriched human hematopoietic progenitor cells: synergistic interaction of GM-CSF plus G-CSF.
McNiece I; Andrews R; Stewart M; Clark S; Boone T; Quesenberry P
Blood; 1989 Jul; 74(1):110-4. PubMed ID: 2473792
[TBL] [Abstract][Full Text] [Related]
5. Effect of pharmacologic manipulation of protein kinase C by phorbol dibutyrate and bryostatin 1 on the clonogenic response of human granulocyte-macrophage progenitors to recombinant GM-CSF.
McCrady CW; Staniswalis J; Pettit GR; Howe C; Grant S
Br J Haematol; 1991 Jan; 77(1):5-15. PubMed ID: 1998597
[TBL] [Abstract][Full Text] [Related]
6. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
Grant S; Pettit GR; McCrady C
Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
[TBL] [Abstract][Full Text] [Related]
7. Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells.
May WS; Sharkis SJ; Esa AH; Gebbia V; Kraft AS; Pettit GR; Sensenbrenner LL
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8483-7. PubMed ID: 3317410
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant granulocyte-macrophage colony stimulating factor and interleukin 3 have overlapping but distinct hematopoietic activities.
Emerson SG; Yang YC; Clark SC; Long MW
J Clin Invest; 1988 Oct; 82(4):1282-7. PubMed ID: 3049674
[TBL] [Abstract][Full Text] [Related]
9. Effects of recombinant human G-CSF, GM-CSF, IL-3, and IL-1 alpha on the growth of purified human peripheral blood progenitors.
Takaue Y; Kawano Y; Reading CL; Watanabe T; Abe T; Ninomiya T; Shimizu E; Ogura T; Kuroda Y; Yokobayashi A
Blood; 1990 Jul; 76(2):330-5. PubMed ID: 1695111
[TBL] [Abstract][Full Text] [Related]
10. Multi-level effects of flt3 ligand on human hematopoiesis: expansion of putative stem cells and proliferation of granulomonocytic progenitors/monocytic precursors.
Gabbianelli M; Pelosi E; Montesoro E; Valtieri M; Luchetti L; Samoggia P; Vitelli L; Barberi T; Testa U; Lyman S
Blood; 1995 Sep; 86(5):1661-70. PubMed ID: 7544638
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 interacts with interleukin-4 and other hematopoietic growth factors to selectively enhance the growth of megakaryocytic, erythroid, myeloid, and multipotential progenitor cells.
Rennick D; Jackson J; Yang G; Wideman J; Lee F; Hudak S
Blood; 1989 May; 73(7):1828-35. PubMed ID: 2469502
[TBL] [Abstract][Full Text] [Related]
12. Human serum megakaryocyte colony-stimulating activity appears to be distinct from interleukin-3, granulocyte-macrophage colony-stimulating factor, and lymphocyte-conditioned medium.
Mazur EM; Cohen JL; Newton J; Sohl P; Narendran A; Gesner TG; Mufson RA
Blood; 1990 Jul; 76(2):290-7. PubMed ID: 2196090
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors.
Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM
Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933
[TBL] [Abstract][Full Text] [Related]
14. Effect of a combined exposure to cytosine arabinoside, bryostatin 1, and recombinant granulocyte-macrophage colony-stimulating factor on the clonogenic growth in vitro of normal and leukemic human hematopoietic progenitor cells.
Grant S; Traylor R; Bhalla K; McCrady C; Pettit GR
Leukemia; 1992 May; 6(5):432-9. PubMed ID: 1593908
[TBL] [Abstract][Full Text] [Related]
15. Modulation by bryostatin 1 of the in vitro radioprotective effects of the GM-CSF/IL-3 fusion protein, PIXY 321, on normal human myeloid progenitors.
Grant S; Traylor R; Pettit GR; Lin PS
Cytokine; 1993 Sep; 5(5):490-7. PubMed ID: 8142605
[TBL] [Abstract][Full Text] [Related]
16. Effects of recombinant human granulocyte colony-stimulating factor (CSF), human granulocyte macrophage-CSF, and gibbon interleukin-3 on hematopoiesis in human long-term bone marrow culture.
Coutinho LH; Will A; Radford J; SchirĂ³ R; Testa NG; Dexter TM
Blood; 1990 Jun; 75(11):2118-29. PubMed ID: 1693295
[TBL] [Abstract][Full Text] [Related]
17. A monoclonal antibody that inhibits the action of GM-CSF on normal but not leukaemic progenitors.
Ashman LK; Cambareri AC; Eglinton JM
Leuk Res; 1990; 14(7):637-44. PubMed ID: 1697006
[TBL] [Abstract][Full Text] [Related]
18. Bryostatin 1 acts synergistically with interleukin-1 alpha to induce secretion of G-CSF and other cytokines from marrow stromal cells.
Lilly M; Vo K; Le T; Takahashi G
Exp Hematol; 1996 Apr; 24(5):613-21. PubMed ID: 8605966
[TBL] [Abstract][Full Text] [Related]
19. In vitro differentiation and proliferation of human hematopoietic progenitors: the effects of interleukins 1 and 6 are indirectly mediated by production of granulocyte-macrophage colony-stimulating factor and interleukin 3.
Migliaccio G; Migliaccio AR; Adamson JW
Exp Hematol; 1991 Jan; 19(1):3-10. PubMed ID: 1989893
[TBL] [Abstract][Full Text] [Related]
20. Bryostatin 1 modulates the proliferation and lineage commitment of human myeloid progenitor cells exposed to recombinant interleukin-3 and recombinant granulocyte-macrophage colony-stimulating factor.
Li F; Grant S; Pettit GR; McCrady CW
Blood; 1992 Nov; 80(10):2495-502. PubMed ID: 1421372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]